[go: up one dir, main page]

FI863797L - Peptidas specifik foer n-terminal mentionin, producering och anvaendning av densamma. - Google Patents

Peptidas specifik foer n-terminal mentionin, producering och anvaendning av densamma. Download PDF

Info

Publication number
FI863797L
FI863797L FI863797A FI863797A FI863797L FI 863797 L FI863797 L FI 863797L FI 863797 A FI863797 A FI 863797A FI 863797 A FI863797 A FI 863797A FI 863797 L FI863797 L FI 863797L
Authority
FI
Finland
Prior art keywords
mentionin
specifik
producering
peptidas
densamma
Prior art date
Application number
FI863797A
Other languages
English (en)
Finnish (fi)
Other versions
FI863797A0 (fi
Inventor
Arie Ben-Bassat
Keith Alan Bauer
Shing Chang
Sheng-Yung Chang
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/778,414 external-priority patent/US4870017A/en
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of FI863797A0 publication Critical patent/FI863797A0/fi
Publication of FI863797L publication Critical patent/FI863797L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/141Interleukin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/30Signal or leader sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI863797A 1985-09-20 1986-09-19 Peptidas specifik foer n-terminal mentionin, producering och anvaendning av densamma. FI863797L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/778,414 US4870017A (en) 1985-09-20 1985-09-20 Bacterial methionine N-terminal peptidase
US06/860,330 US4865974A (en) 1985-09-20 1986-05-06 Bacterial methionine N-terminal peptidase

Publications (2)

Publication Number Publication Date
FI863797A0 FI863797A0 (fi) 1986-09-19
FI863797L true FI863797L (fi) 1987-03-21

Family

ID=27119447

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863797A FI863797L (fi) 1985-09-20 1986-09-19 Peptidas specifik foer n-terminal mentionin, producering och anvaendning av densamma.

Country Status (9)

Country Link
US (1) US4865974A (fr)
EP (1) EP0219237A1 (fr)
JP (1) JP2569218B2 (fr)
AU (1) AU596810B2 (fr)
CA (1) CA1338642C (fr)
DK (1) DK448286A (fr)
FI (1) FI863797L (fr)
IL (1) IL80076A0 (fr)
NO (1) NO863596L (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK55685A (da) * 1985-02-07 1986-08-08 Nordisk Gentofte Enzym eller enzymkompleks med proteolytisk aktivitet
US5013662A (en) * 1985-09-20 1991-05-07 Cetus Corporation Bacterial methionine n-terminal peptidase
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
GB8703015D0 (en) * 1987-02-10 1987-03-18 Biogen Nv Aminopeptidase
DE3811921A1 (de) * 1988-04-09 1989-10-19 Hoechst Ag Verfahren zur herstellung von proteinen, die n-terminal mit prolin beginnen
JPH04500155A (ja) * 1988-08-26 1992-01-16 ザ・ジェネラル・ホスピタル・コーポレイション メチオニン特異的アミノペプチダーゼ:mas iおよびmas xの単離、精製および特性確認
AU4188189A (en) * 1988-09-13 1990-04-02 General Hospital Corporation, The Isolation, purification, and characterization of the aminopeptidases: mas ii and mas iii
AU4213489A (en) * 1988-09-13 1990-04-02 General Hospital Corporation, The Isolation, purification, and characterization of the aminopeptidases: ap1 and ap122
AU4221089A (en) * 1988-09-13 1990-04-02 General Hospital Corporation, The Isolation, purification, and characterization of the aminopeptidases: ap2, ap1, and apx
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
CA2096418C (fr) 1990-11-26 2001-11-20 Philip J. Barr Expression de pace dans les cellules-hotes et modes d'utilisation
ES2293701T3 (es) * 1991-07-24 2008-03-16 Novartis Ag Vector de expresion para prolilendopeptidasas de flavobacterium meningosepticum.
GB9225021D0 (en) * 1992-11-30 1993-01-20 Sandoz Ltd Organic compounds
US6127144A (en) * 1993-12-23 2000-10-03 Cangene Corporation Method for expression of proteins in bacterial host cells
US5616485A (en) * 1993-12-23 1997-04-01 Cangene Corporation Streptomyces proteases and improved streptomyces strains for expression of peptides and polypeptides
US5629167A (en) 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US5753465A (en) * 1994-08-30 1998-05-19 Carnegie Mellon University Unmodified recombinant human adult hemoglobin production
NO944411L (no) * 1994-11-17 1996-05-20 Leiv Sigve Haavarstein Endoprotease med en ny spaltningsspesifisitet
US5843888A (en) * 1995-05-01 1998-12-01 Carnegie Mellon University Low oxygen affinity mutant hemoglobin
US5885820A (en) * 1996-01-31 1999-03-23 St. Louis University Clone of a nucleotide sequence encoding a protein having two functions
KR100369839B1 (ko) * 1997-02-28 2003-06-12 주식회사 엘지생명과학 바실러스리케니포미스균주에서유래한아미노펩티다제,그의제조방법및이를이용한천연형단백질의제조방법
BR9813930A (pt) 1997-11-06 2006-12-19 Chiron Spa antìgeno neisserial
WO1999036544A2 (fr) 1998-01-14 1999-07-22 Chiron S.P.A. Antigenes du $i(neisseria meningitidis)
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
CN101293920B (zh) 1998-05-01 2012-07-18 诺华疫苗和诊断公司 脑膜炎奈瑟球菌抗原和组合物
JP2003518363A (ja) 1999-04-30 2003-06-10 カイロン エセ.ピー.アー. 保存されたナイセリア抗原
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
DK1801219T3 (en) 1999-10-29 2015-12-07 Glaxosmithkline Biolog Sa Neisseriale antigenic peptides.
ES2588917T3 (es) 2000-01-17 2016-11-07 Glaxosmithkline Biologicals Sa Vacuna de VME suplementada contra meningococo
US7816098B2 (en) * 2000-01-31 2010-10-19 Sense Proteomic Limited Methods of making and using a protein array
AU2002214127B2 (en) 2000-10-27 2007-06-07 J. Craig Venter Institute, Inc. Nucleic acids and proteins from streptococcus groups A and B
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
US20050232936A1 (en) 2001-07-27 2005-10-20 Chiron Corporation Meningococcus adhesins nada, app and orf 40
PT1432793E (pt) * 2001-09-13 2009-11-24 Genentech Inc Aminopeptidase b2324
NZ546711A (en) 2001-12-12 2008-06-30 Chiron Srl Immunisation against chlamydia trachomatis
ATE466875T1 (de) 2002-11-15 2010-05-15 Novartis Vaccines & Diagnostic Unerwartete oberflächenproteine in neisseria meningitidis
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
EP2054431B1 (fr) 2006-06-09 2011-08-31 Novartis AG Conformères d'adhésines bactériennes
WO2009104097A2 (fr) 2008-02-21 2009-08-27 Novartis Ag Polypeptides fhbp à méningocoques
KR101041986B1 (ko) 2008-03-06 2011-06-16 (주)한국비엠아이 인간 인터루킨-2의 대량 생산을 위한 신규한 균주
US20110076300A1 (en) 2009-08-27 2011-03-31 Mariagrazia Pizza Hybrid Polypeptides Including Meningococcal fHBP Sequences
JP5960055B2 (ja) 2009-10-27 2016-08-02 ノバルティス アーゲー 改変髄膜炎菌fHBPポリペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60184A (en) * 1979-05-31 1984-05-31 Schering Ag Process for the specific cleavage of protein sequences from proteins
US4350764A (en) * 1980-03-10 1982-09-21 The Regents Of The University Of California Microbiological synthesis of beta endorphin
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
DE3327007A1 (de) * 1983-07-27 1985-02-07 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit einem saeureamid-carboxyterminus
JPS6041697A (ja) * 1983-08-15 1985-03-05 Asahi Chem Ind Co Ltd 活性蛋白質誘導体の新規合成法
DE3588249T2 (de) * 1984-08-16 2004-05-06 Savient Pharmaceuticals, Inc. Methode zur Herstellung von menschlichen Wachstumshormonen

Also Published As

Publication number Publication date
US4865974A (en) 1989-09-12
CA1338642C (fr) 1996-10-15
AU6294486A (en) 1987-03-26
JP2569218B2 (ja) 1997-01-08
FI863797A0 (fi) 1986-09-19
EP0219237A1 (fr) 1987-04-22
JPH03277287A (ja) 1991-12-09
NO863596L (no) 1987-03-23
DK448286A (da) 1987-03-21
DK448286D0 (da) 1986-09-18
AU596810B2 (en) 1990-05-17
NO863596D0 (no) 1986-09-09
IL80076A0 (en) 1986-12-31

Similar Documents

Publication Publication Date Title
FI863797L (fi) Peptidas specifik foer n-terminal mentionin, producering och anvaendning av densamma.
FI860265L (fi) Anvaendning av en fibervaev innefattande mikrosfaerer foer tillverkning av foerstaerkta foeremaol, foerstaerkta foeremaol och saett foer tillverkning av en fibervaev innefattande mikrosfaerer.
FI860232A0 (fi) Tiazolidindionderivat, deras framstaellning och anvaendning.
FI863786L (fi) Mikrocellulaera, energihaltiga kompositmaterialer och foerfarande foer deras framstaellning.
FI860153L (fi) Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning.
FI870012A0 (fi) Medelst kopplingsreaktion erhaollna fosforhaltiga amider, deras prekursorer och dessa innehaollande smoerjmedelkompositioner.
FI863097L (fi) Absorberande stomme avsedd foer engaongsartiklar saosom bloejor, sanitetsbindor och dylika.
FI862727L (fi) Vattenbaserade, av flere komponenter bestaoende polymerkompositioner och foerfarande foer framstaellning av dessa.
FI862029A0 (fi) Askorbinsyraderivat, deras framstaellning och anvaendning.
FI863041L (fi) Fusionsprotein, foerfarande foer deras framstaellning och deras anvaendning.
FI863661A0 (fi) Benzimidazolderivat, deras framstaellning och terapeutiska anvaendning.
FI863798L (fi) Tvaettmedel innehaollande polyeterkarbonsyraderivat, deras framstaellning och anvaendning.
FI865264L (fi) Foerfarande foer anvaendning av en spektralskiftskaernreaktor och en kaernreaktor, i vilken anvaends vatten undantraengande knippen.
FI862374A0 (fi) Foerfarande och anordning foer rundning av plaot, saerskilt foer doskroppar.
FI870734A0 (fi) Magnetiskt oevervakningssystem foer foeremaol, foerfarande och kodad markoer.
FI864636L (fi) Taetningsdelar, foerslutningar och behaollare.
FI862691A0 (fi) 2-oxy-4h-3,1-benzoxazin-4-on-derivat och deras foereningar.
FI862478L (fi) Vattenbaserade, filmbildande oeverdragskompositioner och deras anvaendning.
FI863480A0 (fi) Azolyl-cyklopropyl-etanolderivat, foerfarande foer deras framstaellning och deras anvaendning.
FI863365L (fi) Indolinonderivat, foerfarande foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI860870A0 (fi) Antibakteriska foereningar, deras framstaellning och anvaendning.
FI853787A0 (fi) Elektronisk fjaerrstyrnings- och fjaerrmaetningssystem, speciellt foer foerutsaegning och styrning av foeroreningsaemnen.
FI871428A0 (fi) Framstaellning av allylamin och, utgaoende fraon denna, kvaternaera diallylammoniumfoereningar.
FI864566L (fi) Nitroantracykliner, foerfarande foer deras framstaellning och deras anvaendning.
FI862851A0 (fi) Morfoliniokarboxylsyraester- och morfolinioalkylfenyletersalter, deras framstaellningsfoerfarande och deras anvaendning saosom fungicider.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: CETUS CORPORATION